Bio Key International Inc
BKYI· Nasdaq
Released Aug 13, 2026, after the close
10-Q filed Aug 13, 2026, 44 days after period end · 0001437749-26-027723
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.92M | $1.70M | $1.14M | $1.93M |
| Net Income | -$576.85K | -$1.17M | -$1.67M | -$2.48M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end
23.7% from the close of Aug 10, 2026 to the close of Aug 17, 2026, the first after the release.